Detected ·
Kanvas Biosciences
——
US clinical-stage oncology company Kanvas Biosciences raised Series A funding with participation from the Gates Foundation, signaling potential for microbiome-based checkpoint inhibitor synergy therapy deployment in low- and middle-income countries.
- Website
- —
- —
- Amount
- —
- Stage
- —
- Event
- Funding round
- Detected
- 2026-05-09 08:03:41 UTC
- Signal ID
- 6f8f35de-e0ee-4eb4-83ab-dad7e4c5f4ea
As the API returns it
{
"id": "6f8f35de-e0ee-4eb4-83ab-dad7e4c5f4ea",
"created_at": "2026-05-09T08:03:41.113354Z",
"company_name": "Kanvas Biosciences",
"company_website_url": null,
"company_linkedin_url": null,
"event_type": "funding",
"funding_amount": null,
"funding_currency": null,
"funding_stage": null,
"message": "*US clinical-stage oncology company Kanvas Biosciences raised Series A funding with participation from the Gates Foundation, signaling potential for microbiome-based checkpoint inhibitor synergy therapy deployment in low- and middle-income countries.*"
}